Brief: Sequent Scientific Says NCLT Approved Composite Scheme Between Co, Strides Shasun, Solara Active Pharma Sciences
March 23 (Reuters) - Sequent Scientific Ltd SEQU.NS :
* NCLT APPROVED COMPOSITE SCHEME INVOLVING DEMERGER OF
COMMODITY
API BUSINESS OF STRIDES, HUMAN API BUSINESS OF CO INTO SOLARA
Source text - http://bit.ly/2pyeydJ
Further company coverage: SEQU.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viyash Scientific
See all newsBrief: Viyash Scientific Says Bioforlife Italia Acquisition Expected To Complete Within Two Months From Sept 8
Brief: Viyash Scientific Ltd June-Quarter Consol Net Profit 658.7 Million Rupees
Brief: Viyash Scientific's Subsidiary To Buy 100% Of Bioforlife Italia
Brief: Viyash Scientific March-Quarter Consol Net Profit 521.1 Million Rupees
Brief: Viyash Scientific Partners With Boehringer Ingelheim In India